Futurelytics Trademark Details
Word Mark | Futurelytics |
---|---|
Status | Alive 688 — Notice of Allowance - Issued |
Current Owner
Roche Molecular Systems, Inc. of Palo Alto, CA
View all trademarks for Roche Molecular Systems, Inc.Serial Number | 86666115 |
---|---|
Status Date | Tuesday, April 19, 2016 |
Filing Date | Tuesday, April 19, 2016 |
Attorney | D. Michael Young |
Correspondent
D. MICHAEL YOUNG
Roche Diagnostics
9115 Hague Rd
Indianapolis, IN 46256-1045
Roche Diagnostics
9115 Hague Rd
Indianapolis, IN 46256-1045
Case File Statements
Goods & Services | Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software |
---|---|
Goods & Services | Data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, providing scientific information on individuals' genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; providing an on-line searchable database in the field of clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information and biomarker information for scientific research purposes |
Pseudo Mark | Future Lytics |
Classifications
International Class Codes |
009
|
---|---|
U.S. Class Codes | 021, 023, 026, 036, 038 |
Status | 6 — Active |
Status Date | Tuesday, June 23, 2015 |
Primary Code | 009 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Tuesday, June 23, 2015 |
Primary Code | 042 |
Trademark Timeline
-
Jun 17 2015Trademark application filed with USPTO
-
Jun 20 2015New Application Entered In Tram
-
Jun 23 2015New Application Office Supplied Data Entered In Tram
-
Jun 24 2015Notice of Pseudo Mark Mailed
-
Aug 31 2015Assigned To Examiner
-
Sep 02 2015Non-Final Action Written
-
Sep 03 2015Non-Final Action Mailed
-
Jan 13 2016Correspondence Received In Law Office
-
Jan 13 2016Teas Response To Office Action Received
-
Jan 14 2016Teas/email Correspondence Entered
-
Jan 20 2016Approved For Pub - Principal Register
-
Feb 03 2016Notice of Publication
-
Feb 23 2016Published For Opposition
-
Apr 19 2016Noa Mailed - Sou Required From Applicant